Summary of study characteristics
| Study characteristics (N=23) | (%) |
|---|---|
| Design | |
| Case series (N≤10) | 6 (26) |
| Uncontrolled cohort (N>10) | 9 (39) |
| Case-control study | 2 (9) |
| Randomised controlled trial | 6 (26) |
| Subjects | |
| Asian alone | 20 (87) |
| Non-Asian | 3 (13) |
| Regimen | |
| Tacrolimus+steroids | 15 (65) |
| Tacrolimus+steroids+mycophenolate | 6 (26) |
| Tacrolimus+steroids+mizoribine | 2 (9) |
| Tacrolimus used as | |
| Induction therapy | 13 (57) |
| Maintenance therapy | 5 (22) |
| Induction and maintenance therapy | 3 (13) |
| Therapy switch* | 2 (9) |
*Study was designed to switch patients from conventional treatment to a tacrolimus-based regimen.